• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2013 年至 2024 年奥立克定(TRV130)研究的全球趋势:文献计量学和知识图谱分析。

Global Trends in Oliceridine (TRV130) Research from 2013 to 2024: A Bibliometrics and Knowledge Graph Analysis.

机构信息

Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.

Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, Liaoning Province, People's Republic of China.

出版信息

Drug Des Devel Ther. 2024 Oct 21;18:4681-4692. doi: 10.2147/DDDT.S475205. eCollection 2024.

DOI:10.2147/DDDT.S475205
PMID:39464167
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11505371/
Abstract

PURPOSE

The adverse effects and drug abuse issues associated with opioid drugs have made finding a safe and effective alternative a focus of research. Oliceridine has attracted attention for its lower adverse reactions, such as respiratory depression and gastrointestinal issues, compared to traditional opioids, and is considered a promising candidate for addressing the current limitations in opioid therapy. This article explored the knowledge structure of oliceridine through bibliometric analysis, highlighting its clinical applications in managing acute pain and its mechanisms that may reduce addiction risk. Our bibliometric analysis highlighted hotspots and trends in oliceridine research, guiding future studies on its safety and efficacy in pain management.

METHODS

This study utilized the Web of Science Core Collection database to search for articles related to oliceridine from 2013 to 2024. Systematic analysis was conducted on publication, country, institution, author, journal, references, and keywords. The software Citespace, Vosviewer, and Bibliometrix were employed to visualize bibliometric analysis.

RESULTS

From 2013 to 2024, 159 articles on oliceridine were published in 98 journals by 158 institutions from 28 countries. The United States has rapidly developed in this field, providing significant momentum. Keyword clustering analysis revealed that research on oliceridine primarily focused on exploring its molecular and pharmacological mechanisms and conducting clinical studies to evaluate its efficacy and safety in pain management. Analyses of the strongest citation bursts with references and keywords indicated that protein-biased ligands and oliceridine were hotspots. The emergence of divergent views regarding oliceridine's biased agonism will lead to future hotspots focusing on the underlying mechanisms of biased signaling by G protein-coupled receptors and drug design.

CONCLUSION

Bibliometric analysis provides insights into the current hotspots and emerging areas of oliceridine, which can guide future research. The widespread attention and clinical application of oliceridine lay a solid foundation for further drug development and clinical trials.

摘要

目的

阿片类药物的不良反应和药物滥用问题使得寻找一种安全有效的替代品成为研究的焦点。与传统阿片类药物相比,奥列利定因其较低的不良反应(如呼吸抑制和胃肠道问题)而引起关注,被认为是解决当前阿片类药物治疗局限性的有前途的候选药物。本文通过文献计量学分析探讨了奥列利定的知识结构,强调了其在急性疼痛管理中的临床应用及其可能降低成瘾风险的机制。我们的文献计量学分析突出了奥列利定研究的热点和趋势,指导了未来关于其在疼痛管理中安全性和有效性的研究。

方法

本研究使用 Web of Science 核心合集数据库,从 2013 年至 2024 年检索了与奥列利定相关的文章。对出版物、国家、机构、作者、期刊、参考文献和关键词进行了系统分析。使用 Citespace、Vosviewer 和 Bibliometrix 软件对文献计量学分析进行可视化。

结果

从 2013 年至 2024 年,来自 28 个国家的 158 个机构在 98 种期刊上发表了 159 篇关于奥列利定的文章。美国在这一领域迅速发展,提供了巨大的动力。关键词聚类分析表明,奥列利定的研究主要集中在探索其分子和药理学机制以及进行临床研究,以评估其在疼痛管理中的疗效和安全性。对参考文献和关键词的最强引文爆发分析表明,蛋白偏向配体和奥列利定是热点。对于奥列利定的偏向激动作用存在不同观点的出现,将导致未来的热点集中在 G 蛋白偶联受体的偏向信号转导的潜在机制和药物设计上。

结论

文献计量学分析提供了奥列利定当前热点和新兴领域的见解,可以指导未来的研究。奥列利定的广泛关注和临床应用为进一步的药物开发和临床试验奠定了基础。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/8da93858e55c/DDDT-18-4681-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/ce0e79fd9793/DDDT-18-4681-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/97b2ddd41f98/DDDT-18-4681-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/900b7a49085e/DDDT-18-4681-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/2960ad5faa3b/DDDT-18-4681-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/8da93858e55c/DDDT-18-4681-g0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/ce0e79fd9793/DDDT-18-4681-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/97b2ddd41f98/DDDT-18-4681-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/900b7a49085e/DDDT-18-4681-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/2960ad5faa3b/DDDT-18-4681-g0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bce/11505371/8da93858e55c/DDDT-18-4681-g0005.jpg

相似文献

1
Global Trends in Oliceridine (TRV130) Research from 2013 to 2024: A Bibliometrics and Knowledge Graph Analysis.2013 年至 2024 年奥立克定(TRV130)研究的全球趋势:文献计量学和知识图谱分析。
Drug Des Devel Ther. 2024 Oct 21;18:4681-4692. doi: 10.2147/DDDT.S475205. eCollection 2024.
2
APOLLO-2: A Randomized, Placebo and Active-Controlled Phase III Study Investigating Oliceridine (TRV130), a G Protein-Biased Ligand at the μ-Opioid Receptor, for Management of Moderate to Severe Acute Pain Following Abdominoplasty.APOLLO-2 研究:一项随机、安慰剂和阳性对照的 III 期研究,旨在评估奥立哌啶(TRV130)治疗腹部整形术后中重度急性疼痛的疗效,奥立哌啶是一种作用于 μ 阿片受体的 G 蛋白偶联配体。
Pain Pract. 2019 Sep;19(7):715-731. doi: 10.1111/papr.12801. Epub 2019 Jun 24.
3
Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain.奥利司他用于治疗术后中重度急性疼痛的安全性评价。
Expert Opin Drug Saf. 2021 Nov;20(11):1291-1298. doi: 10.1080/14740338.2021.1965989. Epub 2021 Aug 20.
4
Biased agonism of clinically approved μ-opioid receptor agonists and TRV130 is not controlled by binding and signaling kinetics.临床上批准的 μ 阿片受体激动剂和 TRV130 的偏性激动作用不受结合和信号转导动力学的控制。
Neuropharmacology. 2020 Apr;166:107718. doi: 10.1016/j.neuropharm.2019.107718. Epub 2019 Jul 24.
5
Bibliometric and visualized analysis on global trends and hotspots of TAK1 in regulated cell death: 1999 to 2024.TAK1 在调控细胞死亡方面的全球趋势和热点的文献计量学和可视化分析:1999 年至 2024 年。
Front Immunol. 2024 Oct 15;15:1437570. doi: 10.3389/fimmu.2024.1437570. eCollection 2024.
6
The Utilization of Mu-Opioid Receptor Biased Agonists: Oliceridine, an Opioid Analgesic with Reduced Adverse Effects.μ-阿片受体偏向性激动剂的利用:奥列吗啡,一种具有降低不良反应的阿片类镇痛药。
Curr Pain Headache Rep. 2019 Mar 18;23(5):31. doi: 10.1007/s11916-019-0773-1.
7
Research Trends in the Application of Artificial Intelligence in Oncology: A Bibliometric and Network Visualization Study.人工智能在肿瘤学应用中的研究趋势:文献计量学和网络可视化研究。
Front Biosci (Landmark Ed). 2022 Aug 31;27(9):254. doi: 10.31083/j.fbl2709254.
8
Knowledge Structure and Emerging Trends of Telerehabilitation in Recent 20 Years: A Bibliometric Analysis CiteSpace.近 20 年远程康复的知识结构和新兴趋势:共词分析 CiteSpace
Front Public Health. 2022 Jun 20;10:904855. doi: 10.3389/fpubh.2022.904855. eCollection 2022.
9
Worldwide Bronchiolitis obliterans research: A bibliometric analysis of the published literature between 2002 and 2022.全球细支气管炎性闭塞症研究:2002 年至 2022 年发表文献的计量分析。
Medicine (Baltimore). 2023 Jul 14;102(28):e34263. doi: 10.1097/MD.0000000000034263.
10
Current perspectives and trends of CD39-CD73-eAdo/A2aR research in tumor microenvironment: a bibliometric analysis.肿瘤微环境中 CD39-CD73-eAdo/A2aR 研究的现状和趋势:文献计量学分析。
Front Immunol. 2024 Aug 12;15:1427380. doi: 10.3389/fimmu.2024.1427380. eCollection 2024.

引用本文的文献

1
A Comparative Evaluation of the Safety and Efficacy of Oliceridine and Sufentanil in Gastrointestinal Endoscopy: A Single-Center, Randomized Controlled Trial.奥利替丁与舒芬太尼在胃肠内镜检查中安全性和有效性的比较评估:一项单中心随机对照试验
Drug Des Devel Ther. 2025 Jun 17;19:5111-5121. doi: 10.2147/DDDT.S512529. eCollection 2025.
2
Bibliometric and Visualization Analysis of DprE1 Inhibitors to Combat Tuberculosis.用于对抗结核病的DprE1抑制剂的文献计量学与可视化分析
Drug Des Devel Ther. 2025 Apr 3;19:2577-2596. doi: 10.2147/DDDT.S515049. eCollection 2025.
3
Knowledge domain and trends in acupuncture for stroke research based on bibliometric analysis.

本文引用的文献

1
Efficacy and safety of oliceridine treatment in patients with postoperative pain: a systematic review and meta-analysis of randomized controlled trials.奥列吗啡用于治疗术后疼痛的疗效和安全性:一项随机对照试验的系统评价和荟萃分析。
Expert Rev Clin Pharmacol. 2023 Jan-Jun;16(6):589-599. doi: 10.1080/17512433.2023.2213889. Epub 2023 May 15.
2
Oliceridine for the Management of Moderate to Severe Acute Postoperative Pain: A Narrative Review.奥昔哌啶用于治疗中重度急性术后疼痛的管理:叙事性综述。
Drug Des Devel Ther. 2023 Mar 22;17:875-886. doi: 10.2147/DDDT.S372612. eCollection 2023.
3
Low Intrinsic Efficacy Alone Cannot Explain the Improved Side Effect Profiles of New Opioid Agonists.
基于文献计量分析的中风研究针灸知识领域与趋势
Front Hum Neurosci. 2025 Mar 19;19:1544812. doi: 10.3389/fnhum.2025.1544812. eCollection 2025.
低内在效能本身并不能解释新型阿片类激动剂改善的副作用谱。
Biochemistry. 2022 Sep 20;61(18):1923-1935. doi: 10.1021/acs.biochem.1c00466. Epub 2021 Sep 1.
4
Safety evaluation of oliceridine for the management of postoperative moderate-to-severe acute pain.奥利司他用于治疗术后中重度急性疼痛的安全性评价。
Expert Opin Drug Saf. 2021 Nov;20(11):1291-1298. doi: 10.1080/14740338.2021.1965989. Epub 2021 Aug 20.
5
Oliceridine is Associated with Reduced Risk of Vomiting and Need for Rescue Antiemetics Compared to Morphine: Exploratory Analysis from Two Phase 3 Randomized Placebo and Active Controlled Trials.与吗啡相比,奥利替丁可降低呕吐风险及急救性止吐药的使用需求:两项3期随机安慰剂和活性对照试验的探索性分析
Pain Ther. 2021 Jun;10(1):401-413. doi: 10.1007/s40122-020-00216-x. Epub 2020 Nov 18.
6
Critical Assessment of G Protein-Biased Agonism at the μ-Opioid Receptor.μ-阿片受体 G 蛋白偏向性激动剂的关键性评估。
Trends Pharmacol Sci. 2020 Dec;41(12):947-959. doi: 10.1016/j.tips.2020.09.009. Epub 2020 Oct 20.
7
Biased versus Partial Agonism in the Search for Safer Opioid Analgesics.在寻找更安全的阿片类镇痛药时,偏倚与部分激动作用的比较。
Molecules. 2020 Aug 25;25(17):3870. doi: 10.3390/molecules25173870.
8
In a Rat Model of Opioid Maintenance, the G Protein-Biased Mu Opioid Receptor Agonist TRV130 Decreases Relapse to Oxycodone Seeking and Taking and Prevents Oxycodone-Induced Brain Hypoxia.在阿片类药物维持的大鼠模型中,基于 G 蛋白的 μ 阿片受体激动剂 TRV130 可减少海洛因觅药和觅药行为的复发,并预防阿片类药物引起的大脑缺氧。
Biol Psychiatry. 2020 Dec 15;88(12):935-944. doi: 10.1016/j.biopsych.2020.02.014. Epub 2020 Feb 24.
9
Low intrinsic efficacy for G protein activation can explain the improved side effect profiles of new opioid agonists.对G蛋白激活的内在效力较低可以解释新型阿片类激动剂改善的副作用情况。
Sci Signal. 2020 Mar 31;13(625):eaaz3140. doi: 10.1126/scisignal.aaz3140.
10
Morphine-induced respiratory depression is independent of β-arrestin2 signalling.吗啡引起的呼吸抑制与β-arrestin2 信号无关。
Br J Pharmacol. 2020 Jul;177(13):2923-2931. doi: 10.1111/bph.15004. Epub 2020 Feb 17.